Related Experiment Video
Updated: Aug 10, 2026
Localization, Identification, and Excision of Murine Adipose Depots
Published on: December 4, 2014
Selective adipose tissue ablation by localized, sustained drug delivery
Thomas P Richardson1, William L Murphy, David J Mooney
1Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109, USA.
Abstract:
The reduction of adipose depots is widely considered to be the optimal approach to limit pathologies associated with obesity. While many current antiobesity strategies are centered on regulating satiety, these approaches typically attempt an overall weight loss and are unable to target distinct adipose depots specifically associated with disease risk. The authors report a novel therapeutic modality utilizing localized and sustained delivery of drugs to provide for the selective ablation of adipose tissue. Using the epididymal fat pad of Sprague-Dawley rats as a model, they injected into the tissue poly(lactide-co-glycolide) microspheres encapsulating tumor necrosis factor-alpha, a well-known regulator of adipose tissue mass. The utility of this approach was investigated in vivo by measuring the fat pad mass relative to the contralateral control within the same animal (n = 4 at each time point) and in vitro by measuring apoptosis in adipose organ cultures. The authors demonstrated control over the localization of tumor necrosis factor-alpha by performing blood analysis. This is the first report of localized drug delivery for adipose tissue ablation, and these results indicate the potential utility of the general tissue ablation approach for treatment of numerous pathologies.
Insights
Researchers developed a new method for targeted fat reduction by delivering drugs directly to specific adipose tissue depots. This localized approach selectively ablates fat, offering a potential treatment for obesity-related diseases.
Area of Science:
- Biomedical Engineering
- Metabolic Diseases
- Pharmacology
Background:
- Obesity-related pathologies necessitate targeted adipose tissue reduction.
- Current anti-obesity strategies often lack specificity for disease-associated fat depots.
- Localized drug delivery offers a novel therapeutic avenue for selective fat ablation.
Purpose of the Study:
- To investigate a novel therapeutic modality for localized and sustained drug delivery.
- To achieve selective ablation of adipose tissue using encapsulated therapeutics.
- To evaluate the efficacy and safety of localized adipose tissue ablation.
Main Methods:
- Utilized poly(lactide-co-glycolide) microspheres encapsulating tumor necrosis factor-alpha.
- Administered injections into the epididymal fat pad of Sprague-Dawley rats.
- Assessed fat pad mass reduction in vivo and apoptosis in vitro.
- Monitored drug localization via blood analysis.
Main Results:
- Demonstrated successful localized delivery and sustained release of tumor necrosis factor-alpha.
- Observed significant reduction in targeted adipose tissue mass compared to controls.
- Confirmed increased apoptosis in adipose organ cultures.
- Verified controlled localization of the therapeutic agent.
Conclusions:
- This study presents the first report of localized drug delivery for adipose tissue ablation.
- The findings indicate the potential utility of this approach for treating obesity-related pathologies.
- Localized drug delivery offers a promising strategy for targeted tissue ablation in various diseases.
More Related Videos
09:01A Technique for Subcutaneous Abdominal Adipose Tissue Biopsy via a Non-diathermy Method
Published on: September 30, 2017
06:33Fabrication of Dissolvable Microneedle Patches Loaded with α-Lactalbumin Nanomicelles for Transdermal Capsaicin Delivery and Adipose Tissue Reduction
Published on: December 30, 2025
